Impact of screening on breast cancer detection. Retrospective comparative study of two periods ten years apart

Objective: The aim of this study was to evaluate changes in the mode of discovery of breast cancer in the last 15 years. We compared two periods separated by a 10-year interval, during which a mass mammographic screening programme was established in our department.

Materials and method: We made a retrospective comparison of the records of female patients with breast cancer diagnosed in our hospital over the period 1986-1989 (first period) and 1997-1999 (second period). The mass screening programme for breast cancer began in 1995.

Results: We collected 372 patients in the first period and 341 in the second. We found a significant change in the mode of the discovery of breast cancer between the two periods: 80.2% versus 51.9%, respectively, of the cases of breast cancer were discovered by breast self-examination, 10.2% versus 13.7% were discovered by a physician, and 4.8% versus 29.1% were discovered by routine mammography as part of an individual or mass screening programme. The mean size of the tumours decreased significantly (2.6 cm versus 2.3 cm: p = 0.019), and the number of tumours with initial metastases or lymph node involvement decreased, almost attaining the level of significance (p = 0.06). It is difficult to compare the survival and disease-free survival curves because of the short follow-up in the second period (median follow-up = 10 months). However, a marked difference appears to be developing (p < 0.0001): patients diagnosed by mammography are showing better survival and disease-free survival compared with the others.

Discussion: We observed that more widespread use of mammography screening for breast cancer led to smaller tumours being discovered during the second period, with less lymph node involvement and less initial metastasis. Breast cancer screening is one of the most intensively evaluated health care practices with eight completed randomized trials yet its net benefit has remained controversial. It has been shown that, at least for patients aged 50 to 70, properly organized mass screening for breast cancer led to a reduction in mortality rate. However, individual breast self-exam, physician and mammographic screening can interfere with assessment of mass screening programmes in terms of individual benefit. In addition, introducing a mass screening programme may induce opportunistic screening in non-invited age groups and influence health behaviour in the target and non target populations. A retrospective study was performed to evaluate the mode of discovery, the diagnostic presentation, and prognostic factors in breast cancer in a French department before and after initiation of a mass-screening programme (MSP).

Breast cancer; Screening; Mammography

[1] De Koning H.J.: "Assessment of nationwide cancer-screemng programmes". Lancet, 2000, 355, 80.

[2] De Haes J. C. J. M., De Koning H.J., Van Oortmarssen G. J. Van Agt H. M. E., De Bruyn A. E., Van der Maas P. J.: "Tbe impact of breast cancer screening programme on quality-adjusted lifeyears". Int. J. Cancer, 1991, 49, 538.

[3] Tabor L. et al.: "Reduction of mortality from breast cancer after mass screening with mammography". Lancet, 1985, 1, 829.

[4] Chu K. C., Smart C.R., Tarone R. E.: "Analysis of breast cancer mortality and stage distribution by age for the health insurance plan clinical trial". J. Natl. Ca. Inst., 1988, 80, 1125.

[5] Verbeek A. L. M. et al.: "Reduction of breast cancer mortality through mass screening with modern mammography: first results of Nijmegen project, 1975-1981 ". Lancet, 1984, 1, 1222.

[6] Menegoz F., Cherie-Challine L.: "Le cancer en France: Incidence et mortalite". Paris, La Documentation Franc;aise. 1996.

[7] DiSaia P. J., Creasman W. T.: "Clinical Gynecologic Oncology". 5th ed., St. Louis, Mosby, 1997.

[8] Schleicher U. M., Ammon J.: "Mode of breast cancer detect10n: a study from German part of the Maas-Rhine-EUREGIO". Eur. J. Cancer Prev., 1998, 7, S41.

[9] Strax P.: "Detection of breast cancer". Cancer, 1990, 66, 1336.

[10] Dowle C. S., Mitchell A., Elston C. W.: "Preliminary results of the Nottingham Breast Self-examination Education Program". Br. J. Surg., 1987, 74, 217.

[11] Jatoi I.: "Breast".Am. J. Surg., 1999, 177, 518.

[12] Koscielny S., Tubiana M., Le M. G.. Valleron A. J., Mouriesse H., Contesso G.: "Breast cancer. Relationship between the size of the primary tumor and the probability of metastatic dissemination" Br. J. Cancer, 1984, 49. 709.

[13] Koscielny S., Tubiana M., Valleron A. J.: "A simulation model of the natural history of human breast cancer". Br. J. Cancer, 1985, 52, 511.

[14] Fisher B., Bauer M., Wickerham D. L., Redmond C., Fisher E. R., Cruz A. B.: "Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update". Cancer, I 983, 52, 1551.

[15] Bremond A.: "Traitement du cancer du sein non metastat1que formes habituelles". Encycl. Med. Chir.,1997, 870.

[16] Early Breast Cancer Trialist Collaborative Group: "Effects of radiotherapy and surgery of early breast cancer. An overview of the randomized trials". N. Engl. J. Med., 1995, 333, 1444.